Effect of olive and sunflower oils on low density lipoprotein level, composition, size, oxidation and interaction with arterial proteoglycans

Atherosclerosis

Volumn 125, Issue 2, 1996, Pages 243-255

  Carmena, Rafael ^a   Ascaso, Juan F ^a   Camejo, Germán ^b,c   Varela, Gregorio ^d   Hurt Camejo, Eva ^c   Ordovas, José M ^e   Martinez Valls, José ^a   Bergstöm, Monica ^b   Wallin, Boel ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b ASTRAZENECA R AND D   (Sweden)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

^d UNIVERSITY OF BURGOS   (Spain)

^e TUFTS UNIVERSITY   (United States)

Author keywords

Diets; LDL affinity to proteoglycans; LDL oxidation; LDL retinol; LDL size; LDL tocopherol; LDL carotene; Olive oil; Sunflower oil

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BETA CAROTENE; COPPER; LINOLEIC ACID; LOW DENSITY LIPOPROTEIN; OLEIC ACID; OLIVE OIL; PROTEOGLYCAN; RETINOL; SUNFLOWER OIL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; BINDING AFFINITY; CLINICAL ARTICLE; FAT INTAKE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; OXIDATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN INTERACTION; PROTEIN MODIFICATION;

EID: 0030572755     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(96)05882-0     Document Type: Article

References (46)

1. [1] Grundy SM, Denke MA. Dietary influences on serum lipids and lipoproteins. J Lipid Res 1990;31:1149-1172.
2. [2] Schaefer EJ, Levy RI, Ernst ND, Van Sant V, Brewer HB. The effects of low cholesterol, high polyunsaturated fat, and low fat diets on serum lipids and lipoprotein cholesterol levels in normal and hypercholesterolemic subjects. Am J Clin Nutr 1981;34:1758-1763.
3. [3] Riccardi G, Revellese AA. An update on monounsaturated fatty acids. Curr Opin Lipidol 1993;4:13-16.
4. [4] International Task Force for Prevention of Coronary Heart Disease. Recommendations of the European Atherosclerosis Society. Nutr Metab Cardiovasc Dis 1992;2:113-156.
5. [5] National Cholesterol Education Program. Second Report of the Expert panel on: Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults. National Institute of Health. NIH Publication No. 93-3095.
6. [6] Morciras-Varela O. The Mediterranean diet in Spain. Eur J Clin Nutr 1989;43:83-87.
7. [7] Steinberg DS, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-924.
8. [8] Esterbauer H, Gebicki J, Puhl H, Jürgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Rad Biol Med 1992;13:341-390.
9. [9] Parthasarathy S, Khoo J, Miller E, Barnett J, Witztum JL, Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 1990;87:3994-3898.
10. [10] Berry EM, Eisenberg S, Hartz, D, Friedlander Y, Norman Y, Kaufmann N, Stein Y. Effects of diets rich in monounsaturated fatty acids on plasma lipoproteins. The Jerusalem Nutrition Study: high MUFAS vs. high PUFAS. Am J Clin Nutr 1991;53:899-907.
11. [11] Reaven P, Parthasarathy P, Grasse BJ, Miller D, Steinberg D, Witztum JL. Effects of oleate-rich and linoleaterich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest 1993;91:668-676.
12. [12] Bonanome A, Pagnan A, Biffanti S, Opportuno A, Sorgato F, Dorella M, Maiorino M, Ursini F. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoprotein to oxidative modifications. Arterioscler Thromb 1992;12:529-533.
13. [13] Tribble DL, Holl DG, Wood PD, Krauss RM. Variations in oxidation susceptibility among six low density lipoprotein subfractions of different density and particle size. Atherosclerosis 1994;93:189-199.
14. [14] Tribble DL, van den Berg JM, Motchnik PA, Ames BN, Lewis DM, Chait A, Krauss RM. Oxidative susceptibility of low density lipoprotein subfractions is related to their ubiquinol-10 and α-tocopherol content. Proc Natl Acad Sci USA 1994;91:1183-1187.
15. [15] Dejager S, Bruckert E, Chapman J. Dense low density lipoprotein subspecies with diminished oxidative resistance predominate in combined hyperlipidemia. J Lipid Res 1993;34:295-308.
16. [16] Camejo G, Hurt-Camejo E, Olsson U, Bondjers G. Proteoglycans and lipoproteins in atherosclerosis. Curr Opin Lipidol 1993;4:385-391.
17. [17] Williams KJ, Tabas I. The response-to-retention hypothesis of early atherogenesis. Arterioscler Thromb Vasc Biol 1995;15:551-561
18. [18] Hurt-Camejo E, Camejo G, Rosengren B, López F, Wiklund O, Bondjers G. Differential uptake of proteoglycan-selected subfractions of low density lipoprotein by human macrophages. J Lipid Res 1990;31:1387-1398.
19. [19] Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol-fed rabbits. I. Focal increases in arterial LDL concentrations precede development of fatty streak lesions. Arteriosclerosis 1989;9:895-907.
20. [20] Cardoso LE, Mourao PA. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler Thromb 1994;14:115-124.
21. [21] Manning JM, Gebre AK, Edwards IJ, Wagner W, Rudel L, Parks JS. Dietary polyunsaturated fat decreases interaction between low density lipoproteins and arterial proteoglycans. Lipids 1994;29:635-641.
22. [22] Report of Panel: Dietary Reference Values for Food Energy and Nutrients for the United Kingdom, 1991. HMSO, Cmd DH RMSS, 41.
23. [23] Riemersma R, Wood D, Butler S, Elton R, Oliver M, Salo M, Nikkari T, Vartiainen G, Puska P, Gey F et al. Linoleic acid content in adipose tissue and coronary heart disease. Br Med J 1986;292:1423-1427.
24. [24] Oliver MF. Linoleic acid, antioxidants and coronary heart disease. Biochem Soc Trans 1990;18:1049-1051.
25. [25] Moreiras O, Carbajal A, Cabrera ML. La composición de los alimentos. Eudema SA, Madrid, 1992.
26. [26] West CE, Van Staveren WA. Food consumption, nutrient intake, and the use of food composition tables. In: Margetts BM and Nelson M. (eds). Design Concepts in Nutritional Epidemiology. Oxford University Press, New York, 1991.
27. [27] Allain CC, Poon LS, Chan CG. Enzymatic determination of total serum cholesterol. Clin Chem 1974;20:470-475.
28. [28] Ter HF, Baarscheer T, Fiolet JW. Influence of free glycerol on enzymatic determination of triglycerides. Clin Chem 1984;30:1102-1103.
29. [29] Burstein M, Scholnick HR, Morfin R. Rapid method for the isolation of lipoproteins from human serum precipitation with polyanions. J Lipid Res 1970;11:583-595.
30. [30] Larson C, Gorman JM, Becker AM. Automated immunoprecipitin system for proteins in body fluids further advances. Advances in Automated Analysis, Technicon International Congress 1972;4:15-17.
31. [31] Hallberg C, Håden M, Hanson G, Pettersson K, Westerlund C, Bondjers G, Östlund-Linqvist A-M, Camejo C. Lipoprotein fractionation in deuterium oxide gradients: a procedure for evaluation of antioxidant binding and susceptibility to oxidation. J Lipid Res 1994;35:1-9.
32. [32] Wallin B, Rosengren B, Shertzer H, Camejo G. Lipoprotein oxidation and measurement of thiobarbituric acid reacting substances formation in a single microtiter plate: its use for the evaluation of antioxidants. Anal Biochem 1993;208:10-15.
33. [33] Camejo G, Linden T, Olsson U, Wiklund O, Lopéz F, Bondjers G. Binding parameters and concentration modulate formation of complexes between LDL and arterial proteoglycans in serum. Atherosclerosis 1989;79:121-128.
34. [34] McNamara J, Campos H, Ordovas J, Peterson J, Wilson P, Shaefer E. Effect of gender, age, and lipid status on low density subfraction distribution. Arteriosclerosis 1987;7:483-490.
35. [35] Carmena R, De Oya M, Ascaso JF, Mata P, Serrano S, Alvarez-Sala L, Martinez-Valls FJ, Rubio MJ. Monounsaturated fatty acids in the diet and plasma lipoproteins. In: Gotto Jr Am and Smith LC. de. (eds). Drugs Affecting Lipid Metabolism. Amsterdam: Elsevier, 1990;249-252.
36. [36] Esterbauer H, Dieber-Rotheneder M, Striegl G, Waeg G. Role of vitamin E in preventing the oxidation of low density lipoprotein. Am J Clin Nutr 1991;53:14S-21S.
37. [37] Livrea MA, Tesoriere L, Bongiorno A, Pintaudi AM, Ciaccio M, Riccio A. Contribution of vitamin A to the oxidation resistance of human low density lipoprotein. Free Rad Biol Med 1995;18:401-409.
38. [38] Stocker R, Bowry VW, Frei B. Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol. Proc Natl Acad Sci USA 1991;88:1646-1650.
39. [39] Abbey M, Belling G, Noakes M, Hirata F, Nestel P. Oxidation of low density lipoproteins: intraindividual variability and the effect of dietary linoleate supplementation. Am J Clin Nutr 1993;57:391-398.
40. [40] Kume N, Cybulsky MI, Gimbrone MA. Lysophosphatidylcholine, a component of atherogenic lipoproteins, induces mononuclear leukocyte adhesion molecules in cultured human and rabbit arterial endothelial cells. J Clin Invest 1992;90:1138-1144.
41. [41] Kume N, Gimbrone MA. Lysophosphatidylcholine transcriptionally induces growth factor gene expression in cultured human endothelial cells. J Clin Invest 1994;93:907-911.
42. [42] Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol fed rabbits. II. Selective retention of LDL versus selective increases in LDL permeability in susceptible sites of arteries. Arteriosclerosis 1989;9:908 918.
43. [43] Hurt-Camejo E, Camejo, G, Rosengren B, López F, Fager G, Bondjers G. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells. Arterioscler Thromb 1992;12:569-583.
44. [44] Camejo G, Acquatella H, LaLaguna F. The interaction of low density lipoproteins with arterial proteoglycans: an additional risk factor? Atherosclerosis 1980;36:55-65.
45. [45] Camejo G. The interaction of lipids and lipoproteins with the intercellular matrix of arterial tissue: Its possible role in atherogenesis. Adv Lipid Res 1982;19:1-54.
46. [46] Lindén T, Bondjers G, Camejo G, Wilhelmsen L, Wiklund O. Affinity of LDL to a human arterial proteoglycan among male survivors of myocardial infarction. Eur J Clin Invest 1989;19:38-44.